ArticleJACC. Basic to translational science2026
Global Burden of Rheumatic Heart Disease (1990-2021), Attributable Risk Factors, and Future Projections.
Article in JACC. Basic to translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Single-Session Transcatheter Aortic and Tricuspid Valve-in-Valve Implantation in a Patient with Prior Multivalve Surgery and a Chronic Transvenous Pacing Lead: A Case-Based Review of Procedural Strategy.Life (Basel, Switzerland) · 2026Article
- Beyond Valve Area: Understanding Exercise Intolerance in Severe Rheumatic Mitral Stenosis.JACC. Asia · 2026Article
- Prognostic value of albumin-related inflammatory ratios for 30-day mortality in rheumatic heart disease: a dual-cohort study with external validation.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatic heart disease (RHD) is a chronic valvular disorder caused by acute rheumatic fever. It mostly affects the mitral valve and leads to thickening. The present study employs the GBD (Global Burden of Diseases, Injuries, and Risk Factors Study 2021) to analyze the global burden of RHD. The study investigates trends in incidence, prevalence, disability-adjusted life-years, and mortality from 1990 to 2021 across regions and 204 countries and territories, exploring difference with sex, age, and sociodemographic index. Two-sample Mendelian randomization identified high systolic blood pressure and high body mass index as causal risk factors for RHD. Although there was a slight increase in age-standardized prevalence and incidence rates, there was a decline in mortality and disability-adjusted life-year rates. Projections indicate a persistent upward trend in the incidence of the condition from 2022 to 2050. The findings emphasize the persistent global burden of RHD and underscore the necessity for targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.